Redenlab welcomes Dr. Peter Gibilisco to our advisory board, reinforcing our patient-centred approach
Redenlab are thrilled to announce that Dr. Peter Gibilisco has joined Redenlab’s advisory board. As a consumer advisor…
Blog
Latest content
Redenlab selected for world-first international collaboration investigating neurofilament light chain and voice for diagnosing dementia
Redenlab are partnering with Monash university, University of Melbourne, Eastern Health, and Invicta to deliver this world-first collaboration…
Simons Searchlight: Researcher Profile: Angela Morgan, PhD
Angela Morgan, PhD, is a National Health and Medical Research Council Elizabeth Blackburn Fellow and leads the Speech…
The L16HTHOUSE Study
L16HTHOUSE is a research trial testing an experimental medication for treating speech, motor, learning, and other developmental delays…
Dietary fat supplement trial for A-T
Ataxia telangiectasia (A-T) is a rare inherited condition that affects the nervous and immune systems. A-T typically impacts…
Temporary Assessment of Language in Kabuki Syndrome (TALK) Study
Speech and language development is a complex, multifactorial process driven by the individual’s ability to process and formulate…
How speech analytics is revolutionizing the monitoring and diagnosis of neurological disorders
Speech analytics is a rapidly evolving technology that is transforming the field of digital medicine by providing advanced…
ARIAS: Zooming in on eye-based biomarkers for Alzheimer’s
Scientists are turning to retinas as a potential screening target for early signs of Alzheimer’s, an incurable neurodegenerative…
Redenlab partners with Curebase to expand data capture capabilities in pharma trials
Curebase, a company dedicated to democratizing clinical trials through a decentralized model is announcing its partnership with Redenlab,…
Redenlab’s Professor Angela Morgan appears on Network 7’s House of Wellness to discuss ground-breaking international study on stuttering
MEDIA RELEASEFRIDAY 15 JULY 2022 As many as 70% of people who experience stuttering have a family member…
Redenlab release 2nd generation iOS product on the App Store
Redenlab’s latest iOS application provides state of the art audio capture, storage and analysis of speech and language…
Redenlab brings on Dr Amir Lahav as Chief of Digital Health and Strategy
Dr Amir Lahav hired as Chief of Digital Health and Strategy. He is a clinical neuroscientist and a…
Redenlab presenting work on speech in ataxia & Parkinson’s disease at Movement Disorders Congress in Nice, France – September 2019
Redenlab scientists will be presenting at the upcoming meetings of #SPATAX & #MDSCongress in France on utility of…
Redenlab partner with Murdoch Childrens Research Institute in pediatric digital speech testing project
Prof Angela Morgan of Murdoch Childrens Research Institute with Prof Barbara Dodd, partnering with Redenlab receive funding from…
Redenlab commence collaboration with UCSF Memory and Aging Center
Working with clinician-scientists from UCSF Memory and Aging Center, Redenlab are providing services to help track changes in…
Redenlab sign agreement with Monash Institute of Cognitive and Clinical Neurosciences
Redenlab are working with the Monash University Sleep group
